Yourgene Health Plc
LSE: YGEN.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Lyn Dafydd Rees
- Employees
- 253
- Headquarters
- Manchester, United Kingdom
- IPO year
- 2002
- Market cap
- £16.4M
- Website
- https://www.yourgene-health.com
Loading YGEN…
Loading profile data…Frequently asked questions about YGEN
What does Yourgene Health Plc (YGEN.L) do?
Yourgene Health Plc, a molecular diagnostic company, researches, develops, and commercializes gene analysis techniques for prenatal screening and other applications in the United Kingdom, rest of Europe, and internationally. It develops in vitro diagnostic products, such as IONA Test, a non-invasive pre-natal test (NIPT) for Down's syndrome, Edw...
Where does YGEN.L trade?
Yourgene Health Plc (YGEN.L) trades on the London Stock Exchange.
What sector is YGEN.L in?
Yourgene Health Plc (YGEN.L) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Yourgene Health Plc?
Lyn Dafydd Rees is the chief executive officer of Yourgene Health Plc (YGEN.L).
Where is Yourgene Health Plc headquartered?
Yourgene Health Plc is headquartered in United Kingdom.
Does YGEN.L pay a dividend?
Yourgene Health Plc (YGEN.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did YGEN.L go public?
Yourgene Health Plc (YGEN.L) completed its initial public offering in 2002.